Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 43

1.

Baseline and Postoperative C-reactive Protein Levels Predict Long-Term Survival After Lung Metastasectomy.

Pastorino U, Morelli D, Leuzzi G, Rolli L, Suatoni P, Taverna F, Bertocchi E, Boeri M, Sozzi G, Cantarutti A, Corrao G, Gronchi A.

Ann Surg Oncol. 2019 Mar;26(3):869-875. doi: 10.1245/s10434-018-07116-7. Epub 2019 Jan 3.

PMID:
30607764
2.

Nomogram-based prediction of cervical dysplasia persistence/recurrence.

Bogani G, Tagliabue E, Ferla S, Martinelli F, Ditto A, Chiappa V, Leone Roberti Maggiore U, Taverna F, Lombardo C, Lorusso D, Raspagliesi F.

Eur J Cancer Prev. 2018 Nov 26. doi: 10.1097/CEJ.0000000000000475. [Epub ahead of print]

PMID:
30489353
3.

EndoDB: a database of endothelial cell transcriptomics data.

Khan S, Taverna F, Rohlenova K, Treps L, Geldhof V, de Rooij L, Sokol L, Pircher A, Conradi LC, Kalucka J, Schoonjans L, Eelen G, Dewerchin M, Karakach T, Li X, Goveia J, Carmeliet P.

Nucleic Acids Res. 2019 Jan 8;47(D1):D736-D744. doi: 10.1093/nar/gky997.

4.

Effect of Tobacco Smoking Cessation on C-Reactive Protein Levels in A Cohort of Low-Dose Computed Tomography Screening Participants.

Gallus S, Lugo A, Suatoni P, Taverna F, Bertocchi E, Boffi R, Marchiano A, Morelli D, Pastorino U.

Sci Rep. 2018 Aug 27;8(1):12908. doi: 10.1038/s41598-018-29867-9.

5.

Quiescent Endothelial Cells Upregulate Fatty Acid β-Oxidation for Vasculoprotection via Redox Homeostasis.

Kalucka J, Bierhansl L, Conchinha NV, Missiaen R, Elia I, Brüning U, Scheinok S, Treps L, Cantelmo AR, Dubois C, de Zeeuw P, Goveia J, Zecchin A, Taverna F, Morales-Rodriguez F, Brajic A, Conradi LC, Schoors S, Harjes U, Vriens K, Pilz GA, Chen R, Cubbon R, Thienpont B, Cruys B, Wong BW, Ghesquière B, Dewerchin M, De Bock K, Sagaert X, Jessberger S, Jones EAV, Gallez B, Lambrechts D, Mazzone M, Eelen G, Li X, Fendt SM, Carmeliet P.

Cell Metab. 2018 Dec 4;28(6):881-894.e13. doi: 10.1016/j.cmet.2018.07.016. Epub 2018 Aug 23.

PMID:
30146488
6.

Impairment of Angiogenesis by Fatty Acid Synthase Inhibition Involves mTOR Malonylation.

Bruning U, Morales-Rodriguez F, Kalucka J, Goveia J, Taverna F, Queiroz KCS, Dubois C, Cantelmo AR, Chen R, Loroch S, Timmerman E, Caixeta V, Bloch K, Conradi LC, Treps L, Staes A, Gevaert K, Tee A, Dewerchin M, Semenkovich CF, Impens F, Schilling B, Verdin E, Swinnen JV, Meier JL, Kulkarni RA, Sickmann A, Ghesquière B, Schoonjans L, Li X, Mazzone M, Carmeliet P.

Cell Metab. 2018 Dec 4;28(6):866-880.e15. doi: 10.1016/j.cmet.2018.07.019. Epub 2018 Aug 23.

PMID:
30146486
7.

Potential impact of introducing a nonavalent HPV vaccination.

Bogani G, Taverna F, Lombardo C, Signorelli M, Chiappa V, Casarin J, Scaffa C, Leone Roberti Maggiore U, Recalcati D, Ditto A, Martinelli F, Borghi C, Perotto S, Ferrero S, Lorusso D, Raspagliesi F.

Int J Gynaecol Obstet. 2018 Sep;142(3):338-342. doi: 10.1002/ijgo.12546. Epub 2018 Jun 28.

PMID:
29858884
8.

Blockade of Myeloid-Derived Suppressor Cell Expansion with All-Trans Retinoic Acid Increases the Efficacy of Antiangiogenic Therapy.

Bauer R, Udonta F, Wroblewski M, Ben-Batalla I, Santos IM, Taverna F, Kuhlencord M, Gensch V, Päsler S, Vinckier S, Brandner JM, Pantel K, Bokemeyer C, Vogl T, Roth J, Carmeliet P, Loges S.

Cancer Res. 2018 Jun 15;78(12):3220-3232. doi: 10.1158/0008-5472.CAN-17-3415. Epub 2018 Apr 19.

PMID:
29674477
9.

Predicting Factors for High-Grade Cervical Dysplasia in Women With Low-Grade Cervical Cytology and Nonvisible Squamocolumnar Junction.

Bogani G, Taverna F, Lombardo C, Ditto A, Martinelli F, Signorelli M, Chiappa V, Leone Roberti Maggiore U, Mosca L, Sabatucci I, Scaffa C, Lorusso D, Raspagliesi F.

Reprod Sci. 2019 Jan;26(1):44-48. doi: 10.1177/1933719118756747. Epub 2018 Feb 5.

PMID:
29402202
10.

Artificial intelligence estimates the impact of human papillomavirus types in influencing the risk of cervical dysplasia recurrence: progress toward a more personalized approach.

Bogani G, Ditto A, Martinelli F, Signorelli M, Chiappa V, Leone Roberti Maggiore U, Taverna F, Lombardo C, Borghi C, Scaffa C, Lorusso D, Raspagliesi F.

Eur J Cancer Prev. 2019 Mar;28(2):81-86. doi: 10.1097/CEJ.0000000000000432.

PMID:
29360648
11.

Early reduction of serum TARC levels may predict for success of ABVD as frontline treatment in patients with Hodgkin Lymphoma.

Guidetti A, Mazzocchi A, Miceli R, Paterno' E, Taverna F, Spina F, Crippa F, Farina L, Corradini P, Gianni AM, Viviani S.

Leuk Res. 2017 Nov;62:91-97. doi: 10.1016/j.leukres.2017.09.018. Epub 2017 Sep 25.

PMID:
28992524
12.

Circulating pre-treatment Epstein-Barr virus DNA as prognostic factor in locally-advanced nasopharyngeal cancer in a non-endemic area.

Alfieri S, Iacovelli NA, Marceglia S, Lasorsa I, Resteghini C, Taverna F, Mazzocchi A, Orlandi E, Guzzo M, Bianchi R, Fanti D, Pala L, Racca S, Dvir R, Quattrone P, Gloghini A, Volpi CC, Granata R, Bergamini C, Locati L, Licitra L, Bossi P.

Oncotarget. 2017 Jul 18;8(29):47780-47789. doi: 10.18632/oncotarget.17822.

13.

Baseline and postoperative C-reactive protein levels predict mortality in operable lung cancer.

Pastorino U, Morelli D, Leuzzi G, Gisabella M, Suatoni P, Taverna F, Bertocchi E, Boeri M, Sozzi G, Cantarutti A, Corrao G.

Eur J Cancer. 2017 Jul;79:90-97. doi: 10.1016/j.ejca.2017.03.020. Epub 2017 May 1.

14.

Retrospective study of the influence of HPV persistence on outcomes among women with high-risk HPV infections and negative cytology.

Bogani G, Taverna F, Lombardo C, Borghi C, Martinelli F, Signorelli M, Leone Roberti Maggiore U, Chiappa V, Scaffa C, Ditto A, Lorusso D, Raspagliesi F.

Int J Gynaecol Obstet. 2017 Jul;138(1):62-68. doi: 10.1002/ijgo.12170. Epub 2017 Apr 27.

PMID:
28388819
15.

Hypoxia determines survival outcomes of bacterial infection through HIF-1alpha dependent re-programming of leukocyte metabolism.

Thompson AA, Dickinson RS, Murphy F, Thomson JP, Marriott HM, Tavares A, Willson J, Williams L, Lewis A, Mirchandani A, Dos Santos Coelho P, Doherty C, Ryan E, Watts E, Morton NM, Forbes S, Stimson RH, Hameed AG, Arnold N, Preston JA, Lawrie A, Finisguerra V, Mazzone M, Sadiku P, Goveia J, Taverna F, Carmeliet P, Foster SJ, Chilvers ER, Cowburn AS, Dockrell DH, Johnson RS, Meehan RR, Whyte MK, Walmsley SR.

Sci Immunol. 2017 Feb 10;2(8). pii: eaal2861. doi: 10.1126/sciimmunol.aal2861.

16.

Inflammatory status and lung function predict mortality in lung cancer screening participants.

Pastorino U, Morelli D, Marchianò A, Sestini S, Suatoni P, Taverna F, Boeri M, Sozzi G, Cantarutti A, Corrao G.

Eur J Cancer Prev. 2018 Jul;27(4):289-295. doi: 10.1097/CEJ.0000000000000342.

17.

The association of pre-treatment HPV subtypes with recurrence of VIN.

Bogani G, Martinelli F, Ditto A, Signorelli M, Taverna F, Lombardo C, Chiappa V, Leone Roberti Maggiore U, Recalcati D, Scaffa C, Perotto S, Sabatucci I, Indini A, Lorusso D, Raspagliesi F.

Eur J Obstet Gynecol Reprod Biol. 2017 Apr;211:37-41. doi: 10.1016/j.ejogrb.2017.01.057. Epub 2017 Feb 1.

PMID:
28178576
18.

C-reactive protein level predicts mortality in COPD: a systematic review and meta-analysis.

Leuzzi G, Galeone C, Taverna F, Suatoni P, Morelli D, Pastorino U.

Eur Respir Rev. 2017 Jan 31;26(143). pii: 160070. doi: 10.1183/16000617.0070-2016. Print 2017 Jan. Review.

19.

Human papillomavirus (HPV) persistence and HPV 31 predict the risk of recurrence in high-grade vaginal intraepithelial neoplasia.

Bogani G, Martinelli F, Ditto A, Taverna F, Lombardo C, Signorelli M, Chiappa V, Leone Roberti Maggiore U, Fontanella C, Sabatucci I, Borghi C, Recalcati D, Indini A, Lorusso D, Raspagliesi F.

Eur J Obstet Gynecol Reprod Biol. 2017 Mar;210:157-165. doi: 10.1016/j.ejogrb.2016.12.020. Epub 2016 Dec 23.

PMID:
28039759
20.

Baseline C-reactive protein level predicts survival of early-stage lung cancer: evidence from a systematic review and meta-analysis.

Leuzzi G, Galeone C, Gisabella M, Duranti L, Taverna F, Suatoni P, Morelli D, Pastorino U.

Tumori. 2016 Oct 13;102(5):441-449. doi: 10.5301/tj.5000522. Epub 2016 Jun 11. Review.

PMID:
27292573
21.

Application of Controlled Shear Stresses on the Erythrocyte Membrane as a New Approach to Promote Molecule Encapsulation.

Casagrande G, Arienti F, Mazzocchi A, Taverna F, Ravagnani F, Costantino M.

Artif Organs. 2016 Oct;40(10):959-970. doi: 10.1111/aor.12662. Epub 2016 Jan 27.

PMID:
26813612
22.

Biological quality control for extracorporeal photochemotherapy: Assessing mononuclear cell apoptosis levels in ECP bags of chronic GvHD patients.

Taverna F, Coluccia P, Arienti F, Birolini A, Terranova L, Mazzocchi A, Rini F, Mariani L, Melani C, Ravagnani F.

J Clin Apher. 2015 Jun;30(3):162-70. doi: 10.1002/jca.21357. Epub 2014 Sep 15.

PMID:
25220858
23.

Testing of human papillomavirus in lung cancer and non-tumor lung tissue.

Galvan A, Noci S, Taverna F, Lombardo C, Franceschi S, Pastorino U, Dragani TA.

BMC Cancer. 2012 Nov 12;12:512. doi: 10.1186/1471-2407-12-512.

24.

Serological proteome analysis of Staphylococcus aureus isolated from sub-clinical mastitis.

Tedeschi G, Taverna F, Negri A, Piccinini R, Nonnis S, Ronchi S, Zecconi A.

Vet Microbiol. 2009 Mar 2;134(3-4):388-91. doi: 10.1016/j.vetmic.2008.08.019. Epub 2008 Aug 27.

PMID:
18835110
25.

Tau is endogenously nitrated in mouse brain: identification of a tyrosine residue modified in vivo by NO.

Nonnis S, Cappelletti G, Taverna F, Ronchi C, Ronchi S, Negri A, Grassi E, Tedeschi G.

Neurochem Res. 2008 Mar;33(3):518-25. Epub 2007 Sep 2.

PMID:
17768677
26.

Tyrosine nitration is a novel post-translational modification occurring on the neural intermediate filament protein peripherin.

Tedeschi G, Cappelletti G, Nonnis S, Taverna F, Negri A, Ronchi C, Ronchi S.

Neurochem Res. 2007 Mar;32(3):433-41.

PMID:
17268851
27.

Characterization of cell wall associated proteins of a Staphylococcus aureus isolated from bovine mastitis case by a proteomic approach.

Taverna F, Negri A, Piccinini R, Zecconi A, Nonnis S, Ronchi S, Tedeschi G.

Vet Microbiol. 2007 Jan 31;119(2-4):240-7. Epub 2006 Oct 13.

PMID:
17046180
28.

Alpha5GABAA receptors mediate the amnestic but not sedative-hypnotic effects of the general anesthetic etomidate.

Cheng VY, Martin LJ, Elliott EM, Kim JH, Mount HT, Taverna FA, Roder JC, Macdonald JF, Bhambri A, Collinson N, Wafford KA, Orser BA.

J Neurosci. 2006 Apr 5;26(14):3713-20.

29.

Impairment in long-term retention but not short-term performance on a water maze reversal task following hippocampal or mediodorsal striatal N-methyl-D-aspartate receptor blockade.

Holahan MR, Taverna FA, Emrich SM, Louis M, Muller RU, Roder JC, McDonald RJ.

Behav Neurosci. 2005 Dec;119(6):1563-71.

PMID:
16420159
30.

Prion protein from Xenopus laevis: overexpression in Escherichia coli of the His-tagged protein and production of polyclonal antibodies.

Pagliato L, Negri A, Nonnis S, Taverna F, Sangiorgio L, Ronchi S, Tedeschi G.

Protein Expr Purif. 2006 Apr;46(2):489-94. Epub 2005 Oct 5.

PMID:
16242957
31.

Defective place cell activity in nociceptin receptor knockout mice with elevated NMDA receptor-dependent long-term potentiation.

Taverna FA, Georgiou J, McDonald RJ, Hong NS, Kraev A, Salter MW, Takeshima H, Muller RU, Roder JC.

J Physiol. 2005 Jun 1;565(Pt 2):579-91. Epub 2005 Mar 17.

32.

Place-cell impairment in glutamate receptor 2 mutant mice.

Yan J, Zhang Y, Jia Z, Taverna FA, McDonald RJ, Muller RU, Roder JC.

J Neurosci. 2002 Feb 1;22(3):RC204.

33.

The influence of glutamate receptor 2 expression on excitotoxicity in Glur2 null mutant mice.

Iihara K, Joo DT, Henderson J, Sattler R, Taverna FA, Lourensen S, Orser BA, Roder JC, Tymianski M.

J Neurosci. 2001 Apr 1;21(7):2224-39.

34.

Endogenous Zn(2+) is required for the induction of long-term potentiation at rat hippocampal mossy fiber-CA3 synapses.

Lu YM, Taverna FA, Tu R, Ackerley CA, Wang YT, Roder J.

Synapse. 2000 Nov;38(2):187-97.

PMID:
11018793
35.
36.

Selective abolition of the NMDA component of long-term potentiation in mice lacking mGluR5.

Jia Z, Lu Y, Henderson J, Taverna F, Romano C, Abramow-Newerly W, Wojtowicz JM, Roder J.

Learn Mem. 1998 Sep-Oct;5(4-5):331-43.

37.

Enhanced LTP in mice deficient in the AMPA receptor GluR2.

Jia Z, Agopyan N, Miu P, Xiong Z, Henderson J, Gerlai R, Taverna FA, Velumian A, MacDonald J, Carlen P, Abramow-Newerly W, Roder J.

Neuron. 1996 Nov;17(5):945-56.

38.

Palmitoylation of the GluR6 kainate receptor.

Pickering DS, Taverna FA, Salter MW, Hampson DR.

Proc Natl Acad Sci U S A. 1995 Dec 19;92(26):12090-4.

39.

Expression of functional metabotropic and ionotropic glutamate receptors in baculovirus-infected insect cells.

Ross SM, Taverna FA, Pickering DS, Wang LY, MacDonald JF, Pennefather PS, Hampson DR.

Neurosci Lett. 1994 May 23;173(1-2):139-42.

PMID:
7936400
40.

Sensitivity of AMPA receptors to pentobarbital.

Taverna FA, Cameron BR, Hampson DL, Wang LY, MacDonald JF.

Eur J Pharmacol. 1994 May 17;267(3):R3-5.

PMID:
8088363
41.
42.

Properties of a recombinant kainate receptor expressed in baculovirus-infected insect cells.

Taverna FA, Hampson DR.

Eur J Pharmacol. 1994 Jan 15;266(2):181-6.

PMID:
8157071
43.

Phosphorylation and modulation of a kainate receptor (GluR6) by cAMP-dependent protein kinase.

Wang LY, Taverna FA, Huang XP, MacDonald JF, Hampson DR.

Science. 1993 Feb 19;259(5098):1173-5.

PMID:
8382377

Supplemental Content

Loading ...
Support Center